|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
|
|---|---|---|---|---|
| Assets | ||||
| Current assets | ||||
| Cash | ||||
| Due from Sponsor | ||||
| Prepaid expenses and insurance | ||||
| Total current assets | ||||
| Deferred offering costs | ||||
| Long-term prepaid insurance | ||||
| Cash and investments held in Trust Account | ||||
| Total Assets | ||||
| Liabilities and Shareholder's Deficit | ||||
| Liabilities, Class A Ordinary Shares Subject to Possible Redemption, and Shareholders' Deficit | ||||
| Current liabilities | ||||
| Accrued expenses | ||||
| Accounts payable and accrued expenses | ||||
| Accrued offering costs | ||||
| IPO Promissory Note - related party | ||||
| Total current liabilities | ||||
| Deferred consulting fees - related party | ||||
| Deferred Fee | ||||
| Total Liabilities | ||||
| Class A Ordinary Shares subject to possible redemption, $0.0001 par value; 23,000,000 and 0 shares at redemption value of approximately $10.23 and $0 per share as of September 30, 2026 and December 31, 2025, respectively | ||||
| Shareholders' Deficit | ||||
| Common stock | ||||
| Class A Ordinary Shares | ||||
| ClassA Ordinary Shares Not Subject to Possible Redemption | ||||
| Total class A Ordinary Shares | ||||
| Class B Ordinary Shares | ||||
| Additional paid-in capital | ||||
| Accumulated deficit | ||||
| Total Shareholders' Deficit | ||||
| Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption, and Shareholders' Deficit |
Loading...